Breast implants linked to increased risk of rare lymphoma cancer, FDA warns

by Michael Heygood

The Food and Drug Administration warns that a rare type of cancer associated with women who have received breast implants has now been linked to at least nine deaths. The FDA first warned about the link between breast implants and anaplastic large-cell lymphoma, a rare cancer affecting the immune system, in 2011.

According to data released by the FDA, the agency has received reports of at least 359 cases of anaplastic large-cell lymphoma among women who received breast implants. In these cases, cancerous cells may develop in the scar tissue that forms around the area of the breast implant.

Anaplastic large-cell lymphoma is usually treatable and is not often fatal. In most cases, women who are diagnosed with the disease can be successfully treated by removing the implant and the tissue around it. However, in some cases, women who are diagnosed with anaplastic large-cell lymphoma may need chemotherapy or radiation treatment.

The FDA says that women who undergo breast implant surgery with textured implants – which have a rough, pebbly surface – are more likely to develop anaplastic large-cell lymphoma than women who undergo surgery with smooth implants. Out of 231 cases of anaplastic large-cell lymphoma reported among women who underwent breast implant surgery where information is available, 203 implant were textured, while 28 were smooth.

The FDA reports that the contents of the implants were less important to determining the risk of anaplastic large-cell lymphoma than the surface. Out of 312 cases with adequate information, about 60% were saline implants and 40% were silicon.

Although the FDA has received hundreds of reports of women who were diagnosed with anaplastic large-cell lymphoma after undergoing breast implant surgery, the agency was uncertain about the total number of lymphoma cases linked to the implants due to a shortage in worldwide data. About 290,000 women underwent breast implant surgery in 2016 alone.

Lawsuits Filed on Behalf of Patients Harmed by Defective Medical Devices

Patients who are injured due to complications caused by medical implants or other medical devices may qualify to take legal action against the manufactures of these products. The first step in filing a product liability lawsuit over a defective medical device is to speak with an attorney who has the training and experience to advise you regarding your legal rights and guide you through the first steps of filing a claim.

The lawyers at Heygood, Orr & Pearson have resolved hundreds of claims involving defective medical products, dangerous drugs, and medical malpractice on the part of doctors or hospitals. Our attorneys have secured verdicts and settlements for our clients totaling more than $200 million. We not only have the financial resources to take a case to trial, but the legal expertise to ensure that your legal rights are protected in a court of law.

At Heygood, Orr & Pearson, we firmly believe that when medical device manufacturers fail to ensure that their products meet basic health and safety standards established by the FDA and other health organizations, they should be held accountable for the harm caused by their products in a court of law. The attorneys at Heygood, Orr & Pearson are dedicated to the belief that all patients should have the right to experienced and qualified legal counsel to ensure that their interests are represented.

For a free legal consultation about your case and to find out more about whether you may qualify to file a lawsuit, contact the lawyers at Heygood, Orr & Pearson by calling toll-free at 1-877-446-9001. You can also reach us by following the link to our free case evaluation form and answering a few simple questions about your case to get started.

by Michael Heygood

Michael Heygood is a licensed attorney and partner at HO&P who focuses on insurance and corporate litigation, and other civil arenas. Michael has been named multiple times to the Super Lawyers List.